ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors Meeting Abstract
| Authors: | Infante, J. R.; Ahlers, C. M.; Hodi, F. S.; Postel-Vinay, S.; Schellens, J. H. M.; Heymach, J.; Autio, K. A.; Barnette, M. S.; Struemper, H.; Watmuff, M.; Paul, E. M.; Kaufman, D. R.; Weber, J. S.; Hoos, A. |
| Abstract Title: | ENGAGE-1: A first in human study of the OX40 agonist GSK3174998 alone and in combination with pembrolizumab in patients with advanced solid tumors |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 168s |
| Language: | English |
| ACCESSION: | WOS:000404665404144 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS3107 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3107 -- Source: Wos |
